Bridging Medical Specialities in the Management of Polycystic Ovary Syndrome: Integrating Lessons from Sodium-glucose Cotransporter-2 Inhibitors into a Holistic Approach. The gene discussed is SLC5A2; the disease is polycystic ovary syndrome.